Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report

BACKGROUND: Pulmonary hypertension (PH) is one of the significant complications of sarcoidosis. In the clinical classification of PH proposed in the recent world symposium of PH 2018, sarcoidosis-associated PH is classified in Group 5. The mechanisms of sarcoidosis-associated PH are very heterogeneo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sumimoto, Keiko, Taniguchi, Yu, Emoto, Noriaki, Hirata, Ken-Ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850610/
https://www.ncbi.nlm.nih.gov/pubmed/33554014
http://dx.doi.org/10.1093/ehjcr/ytaa454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850610/
https://www.ncbi.nlm.nih.gov/pubmed/33554014
http://dx.doi.org/10.1093/ehjcr/ytaa454

Ejemplares similares